Strategic alliances, by providing access to cutting-edge products and technologies, allow the DNAVision research and development team be more efficient and effective. We can therefore continually diversify our products and offer new services.
To date, DNAVision has agreements with the following organizations and companies.
BioVallée is a research centre specialised in life sciences. It is also an incubator of new companies and projects supporting the creation of spin-offs resulting from research activities.
DNAVision arose from the development of research and development programmes in genomics. It is second company to spin-off from BioVallée.
DNAVision is shareholder of the company BV Transgenic services.
BV Transgenic Services provides research and development services related to the animal transgenesis in association with Harlan company (distributor of laboratory animals recognized as European leader) in order to offer a technical support to the scientists.
Henogen is a leading contract biomanufacturing organisation spin-off of the Université Libre de Bruxelles.
Institute for Medical Immunology (IMI) is a research Institute of the ULB supported by the Pharmaceutical company GlaxoSmithKline Biologicals and the Walloon Region with the objective to run research activities in the field of vaccines and allografts, to be a training centre and to exploit research results thanks to a strategic agreement with GSK Bio.
From its inception in 1999, Ipsogen has developed and commercialised unique molecular tools for patient risk stratification, to predict patient response to treatment and to monitor minimal residual disease for haematological malignancies. From this proof of concept, Ipsogen is now leveraging its expertise to address unmet medical needs for solid tumors. As a diagnostic company in oncology, Ipsogen integrates the whole value chain from biomarker discovery to development, validation and registration of accurate diagnostic tools that will help physicians drive prescription and monitor residual disease.
R.E.D. Laboratories is a biotechnology company developing clinical diagnostic tests and therapies for chronic immune diseases. As a specialty clinical laboratory, RED Laboratories provide clinicians, researchers and chronically ill patients with unique and innovative assays to detect immune dysfunctions.They also actively pursue basic research programs to further unravel the mechanisms leading to disease development.
Université Libre de Bruxelles (ULB) has a long tradition of excellence in molecular biology and medicine. There are 250 highly-qualified researchers in the laboratories of the Faculties of Science and Medicine on the Gosselies industrial estate.
ULB researchers have received numerous prestigious prizes (two Nobel and nine Francqui) and have published many articles in international scientific journals.
In the Gosselies Biopark, in which DNAVision is situated, ULB researchers in the Institut de Biologie et de Médecine Moléculaire (IBMM) (biologists, chemists, physicians, information technologists, agronomists, veterinary, surgeons or medical doctors) work together in the areas of virology, immunology, applied genetics, parasitology, bioinformatics, etc.
Members of large European and worldwide research networks, they work with prestigious universities, research centres and institutes in Europe, the United States, Canada, etc.
Université de Liège is at the forefront of research and innovation in many scientific area. There are more than 400 researchers dedicated to medical and agronomical research with an annual budget of more than 25 mio €.
The Institut de Pathologie et de Génétique et Institut de Recherche Scientifique en Pathologie et Génétique is one of eight official human genetics centres and has a staff of around 170, almost a third of whom are medical doctors, biologists and other university graduates.
Members of large European and worldwide research networks, they work with prestigious universities, research centres and institutes in Europe, the United States, Canada, etc.
